Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Advances in Therapy|September 9, 2024
Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2)Eric Simpson, Pablo Fernández-Peñas, Marjolein de Bruin-Weller, et al.
Dermatology (Basel, Switzerland)|July 2, 2025
Lebrikizumab Improved Itch Symptoms and Reduced Itch Interference on Sleep over 52 Weeks in Patients with Moderate-to-Severe Atopic Dermatitis in Two Phase 3 TrialsPeter A Lio, David Rosmarin, Jose-Manuel Carrascosa, et al.
Journal of Cutaneous Pathology|June 2, 2019
The role of gene fusions in melanocytic neoplasmsVictor L Quan, Elnaz Panah, Bin Zhang, et al.
The Lancet. Child & Adolescent Health|June 18, 2019
Paediatric melanoma: clinical update, genetic basis, and advances in diagnosisEmily A Merkel, Lauren S Mohan, Katherine Shi, et al.
Journal of Drugs in Dermatology : JDD|October 7, 2020
Impact of Atopic Dermatitis Lesion Location on Quality of Life in Adult Patients in a Real-world StudyPeter A Lio, Andreas Wollenberg, Jacob P Thyssen, et al.
Biochemistry|January 27, 2007
Structural and functional analysis of the pyocyanin biosynthetic protein PhzM from Pseudomonas aeruginosaJames F Parsons, Bryan T Greenhagen, Katherine Shi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 15, 2022
Magnitude and Time Course of Response to Abrocitinib for Moderate-to-Severe Atopic DermatitisKristian Reich, Peter A Lio, Robert Bissonnette, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|November 3, 2020
Targeted Molecular Therapies in Allergy and RhinologyCecelia C Damask, Matthew W Ryan, Thomas B Casale, et al.
Biochemistry|April 18, 2008
Crystal structure of the pyocyanin biosynthetic protein PhzSBryan T Greenhagen, Katherine Shi, Howard Robinson, et al.
The American Journal of Surgical Pathology|January 15, 2019
Activating Structural Alterations in MAPK Genes Are Distinct Genetic Drivers in a Unique Subgroup Of Spitzoid NeoplasmsVictor L Quan, Bin Zhang, Lauren S Mohan, et al.
Pageof 11